semaglutide cardiovascular risk SELECT Trial Eligibility for Cardiovascular Risk Reduction

Initial Combination Therapy with Metformin A total of 1091 patients with type 2 diabetes and inadequate glycemic control on diet and exercise participated in a 24-week, randomized, double-blind, placebo-controlled factorial study designed to assess the efficacy of sitagliptin as initial therapy in combination with metformin

Possible drug interaction between GLP-1 agonists and oral contraceptives

Es werden zwei Standard-Rahmenbreiten angeboten: die schmale Variante mit ca

Common Causes of Night Sweats Let us explore what causes night sweats in detail

Any remaining water in the vial after one withdrawal should be discarded

With BPC-157, the benefits are unproven and the risks unknown a scenario that challenges the ethical boundaries of clinical practice